Get the Stockscreener App
126.88
0.29%
-0.37
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Teleflex Incorporated stock is traded at $126.88, with a volume of 664.90K.
It is down -0.29% in the last 24 hours and up +13.80% over the past month.
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
See More
Previous Close:
$127.25
Open:
$127.43
24h Volume:
664.90K
Relative Volume:
1.03
Market Cap:
$5.61B
Revenue:
$3.04B
Net Income/Loss:
$191.94M
P/E Ratio:
29.87
EPS:
4.2479
Net Cash Flow:
$396.44M
1W Performance:
+5.29%
1M Performance:
+13.80%
6M Performance:
+3.91%
1Y Performance:
-30.78%
1-Day Range:
$125.72
$127.97
1-Week Range:
$118.70
$136.95
52-Week Range:
$102.58
$185.94
Teleflex Incorporated Stock (TFX) Company Profile
Name
Teleflex Incorporated
Sector
Industry
Phone
610-225-6800
Address
550 E SWEDESFORD RD, WAYNE, PA
Compare TFX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TFX
Teleflex Incorporated
|
126.88 | 5.62B | 3.04B | 191.94M | 396.44M | 4.2479 |
|
ISRG
Intuitive Surgical Inc
|
542.32 | 194.04B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
200.89 | 57.21B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.80 | 38.69B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
252.27 | 36.84B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
267.56 | 19.61B | 2.96B | 487.70M | 344.00M | 6.6758 |
Teleflex Incorporated Stock (TFX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-28-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Feb-28-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-28-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Feb-27-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Jul-01-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-21-23 | Downgrade | Needham | Buy → Hold |
| May-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-26-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-26-22 | Initiated | Mizuho | Neutral |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-29-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-09-22 | Initiated | BofA Securities | Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-07-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-07-21 | Resumed | Raymond James | Outperform |
| Jul-19-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Jan-06-21 | Reiterated | Needham | Buy |
| Nov-02-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-31-20 | Reiterated | Needham | Buy |
| Aug-02-19 | Reiterated | Needham | Buy |
| Jun-11-19 | Initiated | Wells Fargo | Outperform |
| Apr-24-19 | Downgrade | Needham | Strong Buy → Buy |
| Feb-22-19 | Reiterated | Needham | Strong Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Sep-10-18 | Upgrade | Needham | Buy → Strong Buy |
| Aug-03-18 | Reiterated | Needham | Buy |
| May-14-18 | Reiterated | Needham | Buy |
| May-04-18 | Reiterated | Needham | Buy |
| Apr-04-18 | Initiated | Goldman | Neutral |
| Nov-10-17 | Resumed | Piper Jaffray | Overweight |
| Nov-03-17 | Reiterated | Needham | Buy |
| Sep-08-17 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Sep-06-17 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-06-17 | Reiterated | Needham | Buy |
| Mar-07-17 | Initiated | Needham | Buy |
| Jan-06-17 | Upgrade | Jefferies | Hold → Buy |
| Jul-12-16 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Teleflex Incorporated Stock (TFX) Latest News
Teleflex to sell acute care, interventional urology, OEM units for $2.03B - MSN
Medtech in a Minute: Teleflex Divestment & More - Medical Device and Diagnostic industry
Teleflex (NYSE:TFX) Shares Rise After Vascular Acquisition News - Kalkine Media
Wayne’s Teleflex to Sell Three Business Divisions in Two Separate Deals - VISTA.Today
Wells Fargo Maintains Teleflex (TFX) Equal-Weight Recommendation - Nasdaq
Teleflex: Selling, But How Much? (NYSE:TFX) - Seeking Alpha
Teleflex to sell 3 medical technology divisions for a combined $2B - The Business Journals
Teleflex Sells Acute Care, Urology, and Medtech OEM Businesses in $2B Deal - PlasticsToday
Teleflex inks deals to sell 3 businesses for $2B - MedTech Dive
Teleflex to sell trio of business lines in deals totalling over $2bn - Yahoo Finance
US: Montagu and Kohlberg to carve out Teleflex Medical OEM for US$1.5bn - Investors in Healthcare
Teleflex stock price target raised to $139 from $114 at Wells Fargo - Investing.com UK
Teleflex stock rating maintained by Citizens on NewCo sale - Investing.com South Africa
Teleflex Sells Acute Care, Interventional Urology, OEM Businesses For $2.03Bln - Nasdaq
Teleflex Stock (+9.6%) : Portfolio Optimization Ignites Strategic Re-rating - Trefis
Teleflex stock holds steady as Needham maintains rating amid asset sales By Investing.com - Investing.com South Africa
Q3 Earnings Outperformers: Teleflex (NYSE:TFX) And The Rest Of The Surgical Equipment & ConsumablesSpecialty Stocks - Yahoo Finance
Teleflex’s Latest Moves: What’s Next for TFX Stock? - StocksToTrade
Teleflex Incorporated (TFX) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Teleflex stock holds steady as Needham maintains rating amid asset sales - Investing.com Nigeria
Teleflex Announces $2.03 Billion Business Sale Agreements - TipRanks
Teleflex announces $2.03 billion business sale agreements - MSN
Teleflex Inc enters equity purchase agreement with Lotus US BidcoSEC filing - marketscreener.com
Teleflex Stock Gains Momentum Amid Jefferies Global Presentation - StocksToTrade
Teleflex Soars on Strategic Divestitures and $1 Billion Share Buyback Plan - Markets Financial Content
Teleflex Divests Businesses for $2.03B, Announces $1B BuybackStock Up 11%News and Statistics - IndexBox
Why Are Teleflex (TFX) Shares Soaring Today - Finviz
Teleflex stock soars after $2.03B sale of business units and $1B buyback By Investing.com - Investing.com South Africa
Teleflex stock soars after $2.03B sale of business units and $1B buyback - Investing.com UK
Teleflex To Divest Multiple Units In Deals Topping $2B - Law360
Teleflex Medical to Sell for $1.5B - Medical Device and Diagnostic industry
Intersurgical Limited agreed to acquire Acute Care and Interventional Urology businesses of Teleflex for approximately $530 million. - marketscreener.com
Teleflex: Opportunity Amidst Market Challenges? - timothysykes.com
Teleflex Stock (TFX) Soars on a $2B Deal - TipRanks
Teleflex inks $2B in divestment deals for OEM, urology and acute care units - Fierce Biotech
Teleflex Medical OEM is getting sold to private equity firms - medicaldesignandoutsourcing.com
Teleflex Scheduled for Key Presentation at Jefferies Conference - timothysykes.com
Medical device maker Teleflex to divest three units for $2.03 billion - Reuters
Teleflex will sell Acute Care, Urology, OEM businesses for $2.03B - MassDevice
Teleflex selling 3 business units for $2.03B - BioWorld MedTech
Montagu and Kohlberg to acquire Teleflex Medical OEM for $1.5 billion By Investing.com - Investing.com South Africa
Montagu and Kohlberg to acquire Teleflex Medical OEM for $1.5 billion - Investing.com Nigeria
Teleflex to Sell Acute Care, Urology, OEM Businesses for $2B - Medical Product Outsourcing
Montagu and Kohlberg to acquire Teleflex Medical OEM from Teleflex in a $1.5bn carve-out - pehub.com
Teleflex To Divest Acute Care, Interventional Urology, OEM Businesses For $2.03 Bln - Nasdaq
Teleflex to Sell Acute Care, Interventional Urology, OEM Businesses for $2.03 Billion in Cash - marketscreener.com
Teleflex to sell three businesses for $2.03 billion, launches buyback By Investing.com - Investing.com India
Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion - The Manila Times
Teleflex to sell three businesses for $2.03 billion, launches buyback - Investing.com
Teleflex rises after co to sell three of its businesses for $2.03 billion - TradingView
Montagu and Kohlberg to Acquire Teleflex Medical OEM in a Carve-out Transaction - Business Wire
Teleflex Incorporated Stock (TFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.32%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):